The UNC Blood Research Center (BRC) was established to promote interdisciplinary research in non-malignant blood disorders across UNC. It will seek to advance the work in the following specific areas.
One in four of the US population will succumb to a terminal thrombotic event, such as: myocardial infarction, stroke, or venous thromboembolism.
Basic science discoveries have paved the way towards better prophylactic and therapeutic approaches to thrombosis. However, a better understanding of the mechanisms underlying thrombosis and prevention without any risk of bleeding remains an unmet need. The BRC seeks to investigate potential approaches to both aims.
UNC is a world leader in hemophilia, from the development and administration of the first coagulation factor VIII concentrate to the role of the Chapel Hill dog colonies of the Francis Owen Blood Research Center in the pre-clinical testing of protein and gene therapies. The BRC aims to address the broad challenges that remain in numerous other inherited and acquired bleeding disorders.
Sickle cell disease affects approximately 100,000 Americans but accounts for an estimated 300,000 births worldwide every year, primarily in sub-Saharan Africa and the Indian sub-continent.
Compared to many other areas of medicine, the development of impactful therapies in sickle cell disease remains inadequate. We will continue to expand our research efforts to this under-served patient population into the future.
Tuesday 8:30 am
Tuesday 8:30 am
Friday 11:00 am
Tuesday 8:30 am
The symposium planned for 2024 will continue to focus on the latest findings in the field of hemostasis and thrombosis. In addition, we will feature a session to highlight the research of trainees attending the symposium.
Note: This activity has been approved for AMA PRA Category 1 Credit, 10.25 activity credits.
Please contact christine_hill@med.unc.edu with any questions.
Learn more about the symposium
2 weeks ago
Steve Hur, PhD, is one of five recipients of the Postdoctoral Awards for Research Excellence from the UNC Office of Postdoctoral Affairs in recognition of research promise demonstrated by individual postdoctoral scholars. He will present his research during University Research Week in October.
3 weeks ago
UNC BRC faculty members Dr. Stephan Moll (adult hematology) and Dr. Baskin-Miller pediatric Hematology-Oncology) and a former UNC Hematology-Oncology trainee (Dr. Alison Raybould, Richmond, VA)) co-authored a recent New England Journal of Medicine publication of a collaborative investigation documenting an association of adeno virus infection with an anti-platelet-factor-4 (PF4) antibody disorder with severe thrombocytopenia and …
2 months ago
Click here to read the Special Edition Summer Newsletter 2023